Monday, November 18, 2024

Canada’s Politics and Government News Source Since 1989

Monday, November 18, 2024 | Latest Paper

Time to go on offence with Canada’s bio-manufacturing strategy

To ensure we do not experience the same issues in the future around emerging technology platforms, we need to transition from a pandemic focus and execute on a robust manufacturing strategy that leverages Canadian strengths for meaningful benefit to Canada and measurable global leadership.

Opinion
BY MICHAEL MAY
September 13, 2021

Opinion | BY MICHAEL MAY | September 13, 2021

More Opinion

The future of emissions trading: can Canada come up with a business case for a ‘businessman-president’?

OpinionBY ARASH GOLSHAN

From coast to core: why Canada’s cities hold the answer to economic stability

OpinionBY STéPHANE PAQUET, JACQUIE GRIFFITHS

It’s time for Canada to embrace its true identity as a North Pacific, Arctic, and North Atlantic power

OpinionBY ANDREW LATHAM

We need a Team Canada approach to safeguarding our vital interests during the Trump presidency

OpinionBY ERROL MENDES

A missed opportunity in the U.S. election

OpinionBY JOSEPH INGRAM

Related Stories

Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West

OpinionBY STEPHANIE WILLERTH

Canada’s biomedical brain drain is reversing. Let’s continue that trend

OpinionBY MICHAEL MAY, ALLISON BROWN

Talent shortage a priority for biotech sector emerging from pandemic

NewsBY JESSE CNOCKAERT

It’s a generational moment for the life science industry

OpinionBY GORDON C. MCCAULEY

It’s time to use the C word: cure

OpinionBY STéPHANIE MICHAUD